# Alnylam Pharmaceuticals, Inc.: Form 8-K, filed May 27, 2026

- Company: [Alnylam Pharmaceuticals, Inc.](/companies/alny.md) (CIK 1178670)
- Form: 8-K
- Filed: 2026-05-27
- Accepted by EDGAR: May 27, 2026, 16:30 ET
- Period: 2026-05-20
- Accession: 0001628280-26-038499
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1178670/000162828026038499/alny-20260520.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1178670/000162828026038499/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1178670/000162828026038499/alny-20260520.htm

Filed May 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-038499. Last ingested by Listed: Oct 31, 2026, 15:25 ET. No prices; not investment advice.